Abstract:Graphical and Lay Summary The application of the Design‐Build‐Test‐Learn (DBTL) framework in enhancing erythromycin production from Saccharopolyspora erythraea. Through systematic metabolic engineering, a genetically modified strain was developed, showing improved erythromycin synthesis by suppressing the sucC gene and enhancing NADPH availability. Transcriptomic and metabolomic analyses revealed significant metabolic alterations, particularly in central carbon, amino acid, energy, and co‐factor/vitamin metabolism pathways. Despite increased amino acid metabolism leading to nitrogen depletion and potential cellular autolysis during fermentation, refining the process through ammonium sulfate supplementation resulted in a remarkable 43.5% increase in erythromycin yield (1125.66 mg/L). This work highlights the efficacy of the DBTL methodology in optimizing antibiotic production and offers insights into addressing the global challenge of antibiotic resistance. Industrial production of bioactive compounds from actinobacteria, such as erythromycin and its derivatives, faces challenges in achieving optimal yields. To this end, the Design‐Build‐Test‐Learn (DBTL) framework, a systematic metabolic engineering approach, was employed to enhance erythromycin production in Saccharopolyspora erythraea (S. erythraea) E3 strain. A genetically modified strain, S. erythraea E3‐CymRP21‐dcas9‐sucC (S. erythraea CS), was developed by suppressing the sucC gene using an inducible promoter and dcas9 protein. The strain exhibited improved erythromycin synthesis, attributed to enhanced precursor synthesis and increased NADPH availability. Transcriptomic and metabolomic analyses revealed altered central carbon metabolism, amino acid metabolism, energy metabolism, and co‐factor/vitamin metabolism in CS. Augmented amino acid metabolism led to nitrogen depletion, potentially causing cellular autolysis during later fermentation stages. By refining the fermentation process through ammonium sulfate supplementation, erythromycin yield reached 1125.66 mg L−1, a 43.5% increase. The results demonstrate the power of the DBTL methodology in optimizing erythromycin production, shedding light on its potential for revolutionizing antibiotic manufacturing in response to the global challenge of antibiotic resistance.

Improving the level of the cytidine biosynthesis in E. coli through atmospheric room temperature plasma mutagenesis and metabolic engineering

Improvement of uridine production of Bacillus subtilis by atmospheric and room temperature plasma mutagenesis and high-throughput screening

Enhancement of heterologous protein production in Corynebacterium glutamicum via atmospheric and room temperature plasma mutagenesis and high-throughput screening

Modularized Reconstruction of Pyrimidine Pathway in Escherichia Coli for Enhanced Pyrimidine Nucleosides Biosynthesis

Deoxycytidine production by a metabolically engineered Escherichia coli strain

[Metabolic engineering of Escherichia coli for thymidine production]

Multistep construction of metabolically engineered Escherichia coli for enhanced cytidine biosynthesis

Synergistic Application of Atmospheric and Room Temperature Plasma Mutagenesis and Adaptive Laboratory Evolution Improves the Tolerance of Escherichia Coli to L-cysteine.

Heterologous erythromycin production across strain and plasmid construction

Study on Cytidine Producing Strain Based on Cdd Gene Knockout and Pyrimidine Operon Transfer

Developing the E. Coli Platform for Efficient Production of UMP-derived Chemicals

Improvement of Cephalosporin C Production by Recombinant DNA Integration in Acremonium Chrysogenum

Screening of Cytidine-Producing Mutants Based on Feedback-Inhibition Resistance of CTP Synthetase

Enhancing erythromycin production in Saccharopolyspora erythraea through rational engineering and fermentation refinement: A Design‐Build‐Test‐Learn approach

Deoxycytidine production by metabolically engineered Corynebacterium ammoniagenes

Improvement of uridine production in Bacillus subtilis by metabolic engineering

Engineering Escherichia Coli for High-Yielding 2,5-Dimethylpyrazine Synthesis from L-Threonine by Reconstructing Metabolic Pathways and Enhancing Cofactors Regeneration

Reconstructing a Recycling and Nonauxotroph Biosynthetic Pathway in Escherichia Coli Toward Highly Efficient Production of L-citrulline.

High-level living cell production of cytidine-5′-diphosphocholine in metabolically engineered yeast

Systematic Engineering of Escherichia coli for Efficient Production of Pseudouridine from Glucose and Uracil

Improvement of S-adenosyl-L-methionine production in Saccharomyces cerevisiae by atmospheric and room temperature plasma-ultraviolet compound mutagenesis and droplet microfluidic adaptive evolution